Phentermine and topiramate for the management of obesity: a review
Gina Cosentino,1 Ariane O Conrad,2 Gabriel I Uwaifo1 1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA; 2Xavier University of Louisiana College of Pharmacy, New Orleans, LA, USA Abstract: Obesity is now...
Main Authors: | Cosentino G, Conrad AO, Uwaifo GI |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-04-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/phentermine-and-topiramate-for-the-management-of-obesity-a-review-a12673 |
Similar Items
-
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
by: Sweeting AN, et al.
Published: (2014-02-01) -
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
by: Shin JH, et al.
Published: (2013-04-01) -
Combination of Phentermine/Topiramate Er and Liraglutide 3 Mg for Intensive Therapy of Severe Obesity & T2Dm: A Case Series and Brief Review
by: Harris M. Baloch, MD, et al.
Published: (2018-11-01) -
Meta-analysis of Weight Change in the Placebo Groups of Lorcaserin and Phentermine/Topiramate Trials from the FDA Database
by: Korte, Andrew, et al.
Published: (2015) -
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Kwon YJ, et al.
Published: (2021-03-01)